Prevention of host-to-host transmission by SARS-CoV-2 vaccinesSARS-CoV-2 백신에 의한 숙주 간 전파 방지Review Published on 2022-02-012022-09-12 Journal: The Lancet. Infectious Diseases [Category] Fulltext, MERS, 진단, [키워드] approved available data clinical trial Course distribution droplets Effect immunological individual individuals Infection infection with SARS-CoV-2 intramuscular less limit mechanisms mucosa observational study Particle population-level effect prevention Primary infection Randomised trial reduce reducing Replication respiratory epithelia SARS-CoV-2 SARS-CoV-2 vaccine shown symptomatic the vaccine titre Transmissibility Transmission Vaccine viral replication [DOI] 10.1016/S1473-3099(21)00472-2 PMC 바로가기 [Article Type] Review
Analysis of the humoral and cellular immune response after a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors with or without chemotherapy: an update after 6 months of follow-up화학 요법의 유무에 관계없이 PD-1/PD-L1 억제제로 치료받은 암 환자에서 BNT162B2 항 -SARS-COV-2 백신의 전체 과정 후 체액 및 세포 면역 반응의 분석 : 6 개월의 추적 관찰 후 업데이트Article Published on 2022-02-012022-08-31 Journal: ESMO open [Category] COVID19(2023년), MERS, SARS, 바이오마커, [키워드] Analysis analyzed anti-SARS-CoV-2 Anti-spike antibody B.1.1 strain BNT162b2 BNT162b2 anti-SARS-CoV-2 vaccine BNT162b2 vaccine Cancer cancer patient Cancer patients Cell cell death cell-mediated immune cell-mediated immune response Cellular immune response chemo-immunotherapy Chemotherapy Concentration correlation Course COVID-19 vaccine dose enrolled enzyme enzyme-linked immunosorbent evaluated Follow-up highlight humoral IFN-γ immune response immunogenicity Immunoglobulin Immunoglobulin G Immunotherapy inhibitor inhibitors interferon-γ interquartile range IQR median mononuclear cells naïve naïve subjects Neutralizing neutralizing antibody of BNT162b2 Patient PD-1/PD-L1 inhibitors Peripheral blood Peripheral blood mononuclear cells previous study programmed cell death programmed cell death protein Protein quantification quantified reduction reduction in SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 vaccination serum samples significant decrease significantly lower spike-specific T-cell spike-specific T-cell response subject subjects Support T-cell Response the vaccine third dose treated triggering vaccination Vaccine was used [DOI] 10.1016/j.esmoop.2021.100359 PMC 바로가기 [Article Type] Article
Comparison of SARS-CoV-2 antibody response after two doses of mRNA and inactivated vaccines in multiple sclerosis patients treated with disease-modifying therapies질병 조절 요법으로 치료받은 다발성 경화증 환자에서 mRNA와 불활성화 백신 2회 투여 후 SARS-CoV-2 항체 반응의 비교Article Published on 2022-02-012022-09-12 Journal: Multiple sclerosis and related disorders [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] Antibody titer BNT162b2 collected COVID-19 cross-sectional decrease Disease-modifying therapy dose greater healthy controls immune response immune system inactivated Inactivated vaccine Messenger RNA mRNA mRNA vaccine Multiple multiple sclerosis participant patients treated Pfizer/BioNTech Protective risk SARS-CoV-2 SARS-CoV-2 antibody second dose seronegative serum sample significant difference single-center Sinovac the vaccine therapy treated Treatment untreated patient Vaccine vaccine group Vaccines [DOI] 10.1016/j.msard.2022.103486 PMC 바로가기 [Article Type] Article
Immunologic response of mRNA SARS-CoV-2 vaccination in adolescent kidney transplant recipients청소년 신장 이식 환자에서 mRNA SARS-CoV-2 백신 접종의 면역학적 반응Article Published on 2022-02-012022-09-12 Journal: Pediatric Nephrology (Berlin, Germany) [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] Adolescent age anti-S antibody antibody Antibody Response Cellular immune response Corticosteroid COVID-19 COVID-19 infection described dose ENhance evaluated Future General population Immunologic Immunosuppressed Immunosuppression inhibitor IQR kidney transplant kidney transplant recipient lower dose mRNA mRNA vaccine non-responders participant Patient patients pediatric positive positive antibody response Protein regimen reported routine clinical care Safe SARS-CoV-2 SARS-CoV-2 spike SARS-CoV-2 vaccination SARS-CoV-2 vaccine second dose solid organ transplant SOT SOT patient SOT patients Support the median the vaccine treated vaccination vaccine immunogenicity vaccine response Viremia [DOI] 10.1007/s00467-021-05256-9 PMC 바로가기 [Article Type] Article
What is the vaccine effect on reducing transmission in the context of the SARS-CoV-2 delta variant?SARS-CoV-2 델타 변이체의 맥락에서 전염을 줄이는 데 백신이 미치는 영향은 무엇입니까?Comment Published on 2022-02-012022-09-11 Journal: The Lancet. Infectious Diseases [Category] COVID19(2023년), SARS, 변종, [키워드] reducing the SARS-CoV-2 the vaccine Transmission [DOI] 10.1016/S1473-3099(21)00690-3 PMC 바로가기 [Article Type] Comment
Evolution of the SARS-CoV-2 genome and emergence of variants of concernSARS-CoV-2 게놈의 진화와 우려되는 변이체의 출현Review Published on 2022-02-012022-09-11 Journal: Archives of Virology [Category] COVID19(2023년), SARS, 변종, [키워드] accumulation Administered Alpha Antibody neutralization B.1.1.7 B.1.351 B.1.617.2 Beta change changes in chronic infections clade consequence coronavirus described Evolution immune response immune responses imperative Infection initial Lineage mortality rate mortality rates notable observation P.1 promote raised random Recombination recurrent infection Replication RNA SARS-CoV-2 SARS-CoV-2 genome SARS-CoV-2 lineage segregation sequence sequence variation spike gene strain Strains Surveillance the SARS-CoV-2 genome the vaccine Transmission variants variants of concern Variation variations while whole-genome sequencing [DOI] 10.1007/s00705-021-05295-5 PMC 바로가기 [Article Type] Review
Humoral and cell-mediated response against SARS-CoV-2 variants elicited by mRNA vaccine BNT162b2 in healthcare workers: a longitudinal observational study의료 종사자에서 mRNA 백신 BNT162b2에 의해 유발된 SARS-CoV-2 변이체에 대한 체액 및 세포 매개 반응: 종단적 관찰 연구Observational Study Published on 2022-02-012022-09-11 Journal: Clinical microbiology and infection : the official [Category] COVID19(2023년), MERS, SARS, 변종, 임상, 진단, 치료기술, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 administration affected antibody Antibody Response BNT162b2 BNT162b2 vaccine cell-mediated response coronavirus detectable dose effective elicit elicited evaluated exposure to Frequency healthcare healthcare worker humoral Humoral response Increased Increased immunogenicity investigated less mRNA mRNA BNT162b2 vaccine mRNA vaccine Neutralizing antibodies neutralizing antibody no significant difference positive reference strain respiratory Responder responders SARS-CoV-2 SARS-CoV-2 antigen SARS-CoV-2 antigens SARS-COV-2 infection SARS-CoV-2 variant SARS-CoV-2 variants second dose second dose of vaccine sera severe acute respiratory syndrome Coronavirus Strains subject subjects subset sustained T cell T cells T-cell T-cell Response T-cell responses tested the SARS-CoV-2 the vaccine vaccination Vaccine variant variants Viral viral variant Viral variants [DOI] 10.1016/j.cmi.2021.09.016 PMC 바로가기 [Article Type] Observational Study
Impacts of worldwide individual non-pharmaceutical interventions on COVID-19 transmission across waves and spaceArticle Published on 2022-02-012022-10-30 Journal: International Journal of Applied Earth Observation and Geoinformation [Category] COVID-19, [키워드] America Bayesian inference big data caused COVID-19 COVID-19 infection COVID-19 pandemic COVID-19 transmission declined Diseases Effectiveness Epidemic facial fatigue First wave Impact implementation implication Intervention investigated measure mitigate Multi-scale National Non-pharmaceutical interventions NPI NPIs pandemic reducing spread of COVID-19 synergistic the United State the vaccine USA vaccination Vaccine variants [DOI] 10.1016/j.jag.2021.102649 PMC 바로가기 [Article Type] Article
An update on COVID-19 and pregnancyArticle Published on 2022-02-012022-11-16 Journal: American journal of obstetrics and gynecology [Category] COVID19(2023년), SARS, 치료기술, [키워드] accumulating addition Administered adverse effect Affect age alteration angiotensin-converting enzyme 2 appear Cell center comparable Control COVID-19 COVID-19 vaccine death determine Effect Evidence extracorporeal membrane oxygenation fetal fetal death fetus Health Healthcare system improvement incidence increase information intensive care invasive ventilation lack lactating Maternal death Newborn nonpregnant outcome outcomes pandemic perinatal infection Placenta Pneumonia Pregnancy pregnant Preterm birth prevention reported reproductive risk factor SARS-CoV-2 SARS-CoV-2 entry SARS-COV-2 infection severe COVID-19 disease severe disease severity of COVID-19 Stillbirth Support Surveillance susceptibility the United State the vaccine transmembrane serine protease Transmission transmission of SARS-CoV-2 vertical transmission Viremia women [DOI] 10.1016/j.ajog.2021.08.054 PMC 바로가기
Third dose of the BNT162b2 vaccine in heart transplant recipients: Immunogenicity and clinical experience심장 이식 환자에게 BNT162b2 백신 3차 접종: 면역원성과 임상 경험Article Published on 2022-02-012022-09-12 Journal: The Journal of heart and lung transplantation : th [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] adverse events anti-RBD Anti-RBD antibody BNT162b2 BNT162b2 vaccine booster booster dose C-reactive protein cellular immune responses clinical experience Cohort COVID-19 COVID-19 pandemic defined domain dose elicited Heart transplantation homologous humoral IgG IgG anti-RBD immune response Immunocompromised immunogenicity increase in injection investigated likelihood majority Mild mycophenolate Neutralizing antibodies neutralizing antibody neutralizing capacity Pain Patient patients Pfizer populations positive antibody response primary doses RBD recipients reduced rejection repeated safety profile SARS-CoV-2 neutralization second dose Serious Adverse Event Specific T-cell response subset T cell response the vaccine Tolerability vaccine response vaccine-induced antibody response were assessed were recorded [DOI] 10.1016/j.healun.2021.08.010 PMC 바로가기 [Article Type] Article